Viatris Inc. (VTRS) Social Stream



Viatris Inc. (VTRS): $14.64

-0.08 (-0.54%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Viatris Inc (VTRS) Price Targets From Analysts

Use the tables below to see what analysts covering Viatris Inc think about its future price and what recommendations they have for investors and traders.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
8 $24 $15 $19 $15.32 24.02%
10 $24 $15 $19.222 $15.32 25.47%
10 $24 $15 $19 $15.32 24.02%
9 $24 $15 $19 $15.32 24.02%

The Trend in the Analyst Price Target


VTRS's average price target has moved down $0.85 over the prior 31 weeks.

Over the past 48 weeks, VTRS's average upside potential has been 46.22%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-12-09 8 24 15 19.000 12.59 50.91%
2021-12-09 10 24 15 19.000 12.59 50.91%
2021-12-09 9 24 15 19.000 12.59 50.91%
2021-12-09 8 24 15 19.222 12.59 52.68%
2021-12-09 10 24 15 19.222 12.59 52.68%
2021-12-09 9 24 15 19.222 12.59 52.68%
2021-03-05 2 35 15 20.470 13.91 47.16%
2021-03-05 11 35 15 20.470 13.91 47.16%
2021-01-06 18 27 16 21.750 NA NA%
2021-01-06 3 27 16 21.750 NA NA%
2021-01-06 10 27 16 21.750 NA NA%

VTRS Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2.25 2 2 4 0 0 8

The Trend in the Broker Recommendations


VTRS's average broker recommendation rating improved by 0.08 over the prior 153 days.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • In terms of how Viatris Inc fares relative to all US stocks, note that its average analyst price target is higher than 92.99% of that group.
  • Viatris Inc's upside potential (average analyst target price relative to current price) is greater than 47.53% of Pharmaceutical Products stocks.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, Viatris Inc's number of analysts covering the stock is greater than 314.59% of them.
  • In the context of stocks in the large market cap category, Viatris Inc's variance in analysts' estimates is lower than -154.81% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Viatris Inc are GLPG, ELAN and OCDX.

What is the outlook for VTRS? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.8636 seconds.